Eledon Pharmaceuticals
ELDN
ELDN
28 hedge funds and large institutions have $14.3M invested in Eledon Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
-3
Holders Change %
-9.68%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
8
Closed
5
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
-$42K
Top Buyers
1 |
![]()
Ensign Peak Advisors
Salt Lake City,
Utah
|
$1.03M |
2 |
UBS Group
Zurich,
Switzerland
|
$9.1K |
3 |
BlackRock
New York
|
$118K |
4 |
TRCT
Tower Research Capital (TRC)
New York
|
$4K |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
$1.55M |